448 related articles for article (PubMed ID: 33774068)
1. Therapeutic targets in lung tissue remodelling and fibrosis.
Liu G; Philp AM; Corte T; Travis MA; Schilter H; Hansbro NG; Burns CJ; Eapen MS; Sohal SS; Burgess JK; Hansbro PM
Pharmacol Ther; 2021 Sep; 225():107839. PubMed ID: 33774068
[TBL] [Abstract][Full Text] [Related]
2. Commonalities between the pro-fibrotic mechanisms in COPD and IPF.
Murray LA
Pulm Pharmacol Ther; 2012 Aug; 25(4):276-80. PubMed ID: 21983244
[TBL] [Abstract][Full Text] [Related]
3. Beyond TGFβ--novel ways to target airway and parenchymal fibrosis.
Boorsma CE; Dekkers BG; van Dijk EM; Kumawat K; Richardson J; Burgess JK; John AE
Pulm Pharmacol Ther; 2014 Dec; 29(2):166-80. PubMed ID: 25197006
[TBL] [Abstract][Full Text] [Related]
4. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
[TBL] [Abstract][Full Text] [Related]
8. TGF-β activation and lung fibrosis.
Tatler AL; Jenkins G
Proc Am Thorac Soc; 2012 Jul; 9(3):130-6. PubMed ID: 22802287
[TBL] [Abstract][Full Text] [Related]
9. 3D in vitro hydrogel models to study the human lung extracellular matrix and fibroblast function.
Phogat S; Thiam F; Al Yazeedi S; Abokor FA; Osei ET
Respir Res; 2023 Oct; 24(1):242. PubMed ID: 37798767
[TBL] [Abstract][Full Text] [Related]
10. The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases.
Usman K; Hsieh A; Hackett TL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359876
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
12. The extracellular matrix - the under-recognized element in lung disease?
Burgess JK; Mauad T; Tjin G; Karlsson JC; Westergren-Thorsson G
J Pathol; 2016 Dec; 240(4):397-409. PubMed ID: 27623753
[TBL] [Abstract][Full Text] [Related]
13. Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis.
Lambers C; Boehm PM; Karabacak Y; Samaha E; Benazzo A; Jaksch P; Roth M
Biomed Res Int; 2019; 2019():1345402. PubMed ID: 30984775
[TBL] [Abstract][Full Text] [Related]
14. Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.
Liu G; Cooley MA; Jarnicki AG; Borghuis T; Nair PM; Tjin G; Hsu AC; Haw TJ; Fricker M; Harrison CL; Jones B; Hansbro NG; Wark PA; Horvat JC; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM
JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31343988
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
16. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease.
Burgstaller G; Oehrle B; Gerckens M; White ES; Schiller HB; Eickelberg O
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28679607
[TBL] [Abstract][Full Text] [Related]
17. What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?
Gualano RC; Vlahos R; Anderson GP
Pulm Pharmacol Ther; 2006; 19(1):18-23. PubMed ID: 16286234
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
[TBL] [Abstract][Full Text] [Related]
20. Regulation of pulmonary inflammation by mesenchymal cells.
Alkhouri H; Poppinga WJ; Tania NP; Ammit A; Schuliga M
Pulm Pharmacol Ther; 2014 Dec; 29(2):156-65. PubMed ID: 24657485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
